Page last updated: 2024-11-04

rolipram and Pituitary Neoplasms

rolipram has been researched along with Pituitary Neoplasms in 2 studies

Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishiyama, S1
Okudaira, M1
Saito, N1
Gordeladze, JO1

Other Studies

2 other studies available for rolipram and Pituitary Neoplasms

ArticleYear
Mechanisms of rolipram-induced increase in the incidence of mammary adenocarcinoma: histopathological study of a 104-week oral carcinogenicity study in female Sprague-Dawley rats.
    Archives of toxicology, 2006, Volume: 80, Issue:2

    Topics: Adenocarcinoma; Animals; Carcinogenicity Tests; Estradiol; Estrous Cycle; Female; Male; Mammary Neop

2006
The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
    Bioscience reports, 1990, Volume: 10, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenoma; Adenylyl Cyclases; Animals; Colforsin; Cyclic AMP; Enz

1990